KTWO
K2 Capital Acquisition CorporationNASDAQNONENONE
Key Statistics
Market Cap
$199.01M
P/E Ratio
—
EPS
—
Beta
—
52W High
$10.01
52W Low
$9.84
50-Day MA
$9.89
200-Day MA
$9.89
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About K2 Capital Acquisition Corporation
K2M Group Holdings, Inc., a medical device company, offers spinal and minimally invasive solutions in the United States and internationally.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.02 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $14.13M |
| Float | $12.47M |
| % Insiders | 2.31% |
| % Institutions | 13.64% |
More NONE Stocks
SOJESouthern Company (The) Series 2DTBDTE Energy Company 2020 SeriesDTGDTE Energy Company 2021 Series ECGABLThe Carlyle Group Inc. 4.625% Subordinated Notes due 2061MGRBAffiliated Managers Group, Inc.NIQNIQ Global Intelligence plcUZDUnited States Cellular CorporatUZFUnited States Cellular CorporatRILYTB. Riley Financial Inc. 6.00% Senior Notes Due 2028HWCPZHancock Whitney Corporation - 6OXLCLOxford Lane Capital Corp. 6.75% Notes due 2031CCXIChurchill Capital Corp XI
Data last updated: 5/5/2026